3D Bioprinting Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global 3D bioprinting market is set to experience substantial growth, with its value projected to reach $2.6 billion in 2024 and further escalate to $5.9 billion by 2031. This impressive expansion reflects a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031. The surge in demand for organ transplants, rapid technological advancements, and increasing academic interest are key factors driving this market's growth.

Rising Demand in Healthcare for 3D Bioprinting

The healthcare sector has seen a marked increase in demand for 3D bioprinting solutions. These advanced technologies are crucial for developing organs and constructing tissues, which are essential for medical implants and drug-related research and development (R&D) activities. Although still in its nascent stage, the 3D bioprinting market holds tremendous potential for producing human tissue replacements, representing a significant breakthrough in the medical field.

One of the primary uses of 3D bioprinting is drug testing. The capability to test drug compounds on bioprinted tissues before human trials accelerates the drug development process and improves accuracy and efficiency.

Growing Academic Interest in 3D Bioprinting

Academicians worldwide are increasingly focusing on 3D bioprinting. Numerous researchers are founding start-ups to commercialize this innovative technology, developing various products based on bioprinting. For example, Aspect Biosystems is working on printing tissue models for toxicity testing, TeViDo BioDevices is developing breast tissues, and SkinPrint is creating human skin. These advancements highlight the diverse applications of 3D bioprinting technology and its potential to meet critical healthcare needs.

North America: Leading the Market

North America is expected to dominate the global 3D bioprinting market in the coming years. This dominance is attributed to the region's large target population, presence of key market players, and advanced healthcare infrastructure. Additionally, increased R&D investments by regional players are anticipated to further boost market growth in North America.

Recent Market Developments

In March 2022, BICO Group AB (US) launched BIO CELLX, a novel system designed to automate the workflow of 3D cell culture using prevalidated protocols. This innovation marks a significant milestone in the commercialization of 3D bioprinting technology.

Competitive Landscape

Currently, the 3D bioprinting market comprises 14 industry-sponsored bioprinters focused on various commercial applications. Addressing the supply-demand gap for organ transplants remains an unmet need, with researchers striving to create bioprinted organs for future transplants. The market relies on biocompatible materials (bio-ink and bio-paper), software (CAD), and hardware (bioprinters).

The market's focus is expected to shift from research to commercialization, with tissue engineering (skin and cartilage) and drug testing (skin and cartilage) applications gaining popularity. The initial success of bioprinted organ transplants is anticipated to significantly boost the market, potentially transforming it into a multi-billion-dollar industry.

Aspect Biosystems aims to drastically reduce the cost and time required for drug development and testing, leading to treatments for currently incurable diseases and more affordable healthcare options. Other notable companies in the bioprinting market include SkinPrint, which is developing replacement skin for burn patients and individuals with skin disorders, and Advanced Biomatrix, 3D Biotek, 3D Systems, Avita Medical, among others.

Institutional Support and Research Grants

To promote innovation in 3D bioprinting, the U.S. FDA has awarded a grant of $2.5 million to five research institutions for biomanufacturing research, including 3D bioprinting. The recipient institutions are Carnegie Mellon University, Harvard University, Georgia Institute of Technology, Rutgers University, and the Massachusetts Institute of Technology. These grants underscore the importance of collaborative efforts between institutions and industry players to advance the 3D bioprinting market.

Key Market Players Include

Envisiontec, Inc.
Precise Bio
Organovo Holdings, Inc.
Revotek Co., Ltd.
Inventia Life Science PTY LTD
Vivax Bio
Poietis
Allevi
Biomedical K.K.
Cellink Global
Bioprinting Solutions

Global 3D Bioprinting Market Segmentation

By Component:

3D Bioprinters
Bioinks

By Application:

Research Applications
Clinical Applications

By End User:

Research Organization and Academic Institutes
Biopharmaceutical Companies
Hospitals

By Region:

North America
Europe
Latin America
East Asia
The Middle East & Africa
South Asia & Pacific

1. Executive Summary

1.1. Global 3D Bioprinting Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Product Adoption Analysis
2.4. Product USP
2.5. Porter's Five Forces Analysis
2.6. COVID-19 Impact Analysis
- 2.6.1. Supply
- 2.6.2. Demand
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global 3D Bioprinting Market Outlook, 2018 - 2031

3.1. Global 3D Bioprinting Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. 3D Bioprinters
  - 3.1.1.2. Bioinks
3.2. Global 3D Bioprinting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Research Applications
  - 3.2.1.2. Clinical Applications
3.3. Global 3D Bioprinting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Research Organization and Academic Institutes
  - 3.3.1.2. Biopharmaceutical Companies
  - 3.3.1.3. Hospitals
3.4. Global 3D Bioprinting Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America 3D Bioprinting Market Outlook, 2018 - 2031

4.1. North America 3D Bioprinting Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. 3D Bioprinters
  - 4.1.1.2. Bioinks
4.2. North America 3D Bioprinting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Research Applications
  - 4.2.1.2. Clinical Applications
4.3. North America 3D Bioprinting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Research Organization and Academic Institutes
  - 4.3.1.2. Biopharmaceutical Companies
  - 4.3.1.3. Hospitals
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America 3D Bioprinting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe 3D Bioprinting Market Outlook, 2018 - 2031

5.1. Europe 3D Bioprinting Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. 3D Bioprinters
  - 5.1.1.2. Bioinks
5.2. Europe 3D Bioprinting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Research Applications
  - 5.2.1.2. Clinical Applications
5.3. Europe 3D Bioprinting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Research Organization and Academic Institutes
  - 5.3.1.2. Biopharmaceutical Companies
  - 5.3.1.3. Hospitals
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe 3D Bioprinting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific 3D Bioprinting Market Outlook, 2018 - 2031

6.1. Asia Pacific 3D Bioprinting Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. 3D Bioprinters
  - 6.1.1.2. Bioinks
6.2. Asia Pacific 3D Bioprinting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Research Applications
  - 6.2.1.2. Clinical Applications
6.3. Asia Pacific 3D Bioprinting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Research Organization and Academic Institutes
  - 6.3.1.2. Biopharmaceutical Companies
  - 6.3.1.3. Hospitals
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific 3D Bioprinting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America 3D Bioprinting Market Outlook, 2018 - 2031

7.1. Latin America 3D Bioprinting Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. 3D Bioprinters
  - 7.1.1.2. Bioinks
7.2. Latin America 3D Bioprinting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Research Applications
  - 7.2.1.2. Clinical Applications
7.3. Latin America 3D Bioprinting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Research Organization and Academic Institutes
  - 7.3.1.2. Biopharmaceutical Companies
  - 7.3.1.3. Hospitals
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America 3D Bioprinting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa 3D Bioprinting Market Outlook, 2018 - 2031

8.1. Middle East & Africa 3D Bioprinting Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. 3D Bioprinters
  - 8.1.1.2. Bioinks
8.2. Middle East & Africa 3D Bioprinting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Research Applications
  - 8.2.1.2. Clinical Applications
8.3. Middle East & Africa 3D Bioprinting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Research Organization and Academic Institutes
  - 8.3.1.2. Biopharmaceutical Companies
  - 8.3.1.3. Hospitals
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa 3D Bioprinting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa 3D Bioprinting Market by Component, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa 3D Bioprinting Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa 3D Bioprinting Market by End User, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Market Share Analysis, 2023
9.2. Competitive Dashboard
9.3. Company Profiles
- 9.3.1. Envisiontec, Inc.
  - 9.3.1.1. Company Overview
  - 9.3.1.2. Product Portfolio
  - 9.3.1.3. Financial Overview
  - 9.3.1.4. Business Strategies and Development
- 9.3.2. Precise Bio
  - 9.3.2.1. Company Overview
  - 9.3.2.2. Product Portfolio
  - 9.3.2.3. Financial Overview
  - 9.3.2.4. Business Strategies and Development
- 9.3.3. Organovo Holdings, Inc.
  - 9.3.3.1. Company Overview
  - 9.3.3.2. Product Portfolio
  - 9.3.3.3. Financial Overview
  - 9.3.3.4. Business Strategies and Development
- 9.3.4. Revotek Co., Ltd.
  - 9.3.4.1. Company Overview
  - 9.3.4.2. Product Portfolio
  - 9.3.4.3. Financial Overview
  - 9.3.4.4. Business Strategies and Development
- 9.3.5. Inventia Life Science PTY LTD
  - 9.3.5.1. Company Overview
  - 9.3.5.2. Product Portfolio
  - 9.3.5.3. Financial Overview
  - 9.3.5.4. Business Strategies and Development
- 9.3.6. Vivax Bio
  - 9.3.6.1. Company Overview
  - 9.3.6.2. Product Portfolio
  - 9.3.6.3. Financial Overview
  - 9.3.6.4. Business Strategies and Development
- 9.3.7. Poietis
  - 9.3.7.1. Company Overview
  - 9.3.7.2. Product Portfolio
  - 9.3.7.3. Financial Overview
  - 9.3.7.4. Business Strategies and Development
- 9.3.8. Allevi
  - 9.3.8.1. Company Overview
  - 9.3.8.2. Product Portfolio
  - 9.3.8.3. Financial Overview
  - 9.3.8.4. Business Strategies and Development
- 9.3.9. Biomedical K.K.
  - 9.3.9.1. Company Overview
  - 9.3.9.2. Product Portfolio
  - 9.3.9.3. Financial Overview
  - 9.3.9.4. Business Strategies and Development
- 9.3.10. Cellink Global
  - 9.3.10.1. Company Overview
  - 9.3.10.2. Product Portfolio
  - 9.3.10.3. Financial Overview
  - 9.3.10.4. Business Strategies and Development
- 9.3.11. Bioprinting Solutions
  - 9.3.11.1. Company Overview
  - 9.3.11.2. Product Portfolio
  - 9.3.11.3. Financial Overview
  - 9.3.11.4. Business Strategies and Development

10. Appendix

10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations